Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis

This publication has 61 references indexed in Scilit:

• The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes
  American Journal of Obstetrics and Gynecology, 2005
• Comparison of a Multiplexed Fluorescent Covalent Microsphere Immunoassay and an Enzyme-Linked Immunosorbent Assay for Measurement of Human Immunoglobulin G Antibodies to Anthrax Toxins
  Clinical and Vaccine Immunology, 2004
• Comparison of a Multiplex Flow Cytometric Assay with Enzyme-Linked Immunosorbent Assay for Quantitation of Antibodies to Tetanus, Diphtheria, and Haemophilus influenzae Type b
  Clinical and Vaccine Immunology, 2002
• Prevalence of Bacterial Vaginosis and Vaginal Flora Changes in Peri- and Postmenopausal Women
  Journal of Clinical Microbiology, 2002
• Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
  Annals of Oncology, 2002
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999
• The preterm prediction study: Fetal fibronectin, bacterial vaginosis, and peripartum infection
  Obstetrics & Gynecology, 1996
• The Preterm Prediction Study: Fetal Fibronectin, Bacterial Vaginosis, and Peripartum Infection
  Obstetrics & Gynecology, 1996
• Thalidomide and the immune system 3. simultaneous up- and down-regulation of different integrin receptors on human white blood cells
  Life Sciences, 1994
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994